Keyphrases
Anaplastic Large Cell Lymphoma
91%
Mantle Cell Lymphoma
50%
Apoptosis
41%
Anaplastic Lymphoma Kinase
39%
ALK+
39%
Lymphoma Cells
36%
Tumor
35%
Signal Transducer and Activator of Transcription 3
29%
Mammalian Target of Rapamycin (mTOR)
26%
Diffuse Large B-cell Lymphoma (DLBCL)
25%
Lymphoma
24%
Bone Marrow
23%
Cell Cycle Progression
21%
Anaplastic Lymphoma Kinase-positive
21%
Murine Double Minute 4 (MDM4)
20%
Mammalian Target of Rapamycin Signaling
20%
C-Jun
20%
Hematolymphoid Tumors
19%
Pediatric
19%
Cell Cycle Arrest
15%
World Health Organization Classification
15%
Activator protein-1 (AP-1)
15%
Classical Hodgkin Lymphoma
14%
Acute Myeloid Leukemia
14%
Murine Double Minute 2 (MDM2)
13%
Tumor Protein p53 (TP53)
13%
Nutlin-3
13%
Immunophenotypic Profile
13%
Cell Growth
12%
Nucleophosmin 1 (NPM1)
12%
Two-year-olds
12%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
12%
Leukemia
12%
CD30
12%
Molecular Diagnostics
12%
Flow Cytometric
12%
B-cell Lymphoma 2 (Bcl-2)
12%
Cell Tumor
12%
Clinical Significance
12%
P53 Pathway
11%
Expression Pattern
11%
Induced Apoptosis
11%
Immune Response
11%
KMT2A
11%
Signaling Molecules
11%
C-FLIP
11%
Mammalian Target of Rapamycin Signaling Pathway
11%
Germinal Center
10%
B-cell non-Hodgkin Lymphoma (B-NHL)
10%
Clinical Outcomes
10%
Medicine and Dentistry
Neoplasm
100%
Anaplastic Large Cell Lymphoma
48%
Programmed Cell Death
41%
Mantle Cell Lymphoma
38%
B Cell
31%
Diffuse Large B-Cell Lymphoma
25%
Lymphatic System Tumor
25%
Non-Hodgkin Lymphoma
23%
Pediatrics
22%
Tumor Cell
19%
Hodgkin's Lymphoma
19%
STAT3 Protein
19%
Malignant Neoplasm
19%
Classical Hodgkin Lymphoma
18%
Diagnosis
17%
Diseases
15%
Serine
15%
Cell Cycle Arrest
14%
Cell Cycle Checkpoint
14%
Epstein Barr Virus
14%
Acute Myeloid Leukemia
14%
Cell Proliferation
13%
Flow Cytometry
13%
Phosphotransferase
13%
Activator Protein 1
12%
Leukemia
12%
Clinical Significance
12%
Initiation Factor 4E
11%
Nodular Lymphocyte Predominant Hodgkin's Lymphoma
11%
Mechanistic Target of Rapamycin
11%
Molecular Diagnostics
11%
Cell Cycle Progression
11%
extracellular signal regulated kinase
11%
T Cell
10%
Mantle Cell Lymphoma Cell Line
10%
Signaling Protein
10%
Cell Signaling Pathway
10%
Germinal Center
10%
Hematopoietic Tissue
10%
Lymphatic Tissue
10%
Lymphocyte
9%
Gastrointestinal Tract
9%
Receptor
9%
Drug Megadose
9%
microRNA
9%
Myeloid Malignancy
9%
Cytarabine
9%
Protein MDM2
9%
Triple Negative Breast Cancer
9%
Lymphoma
9%
Biochemistry, Genetics and Molecular Biology
Anaplastic Lymphoma Kinase
71%
Programmed Cell Death
50%
STAT3
41%
P53
41%
Phosphotransferase
31%
Kinase
31%
Cell Cycle Progression
23%
Mechanistic Target of Rapamycin
22%
Cell Survival
21%
JUNB
20%
MDM4
20%
Cell Cycle
16%
Cytogenetics
15%
Cell Cycle Checkpoint
14%
Cell Cycle Arrest
14%
CD30
14%
Genomics
14%
Nutlin
12%
Genetics
12%
Fibroblast
12%
T Cell
12%
Cell Growth
11%
Cell Proliferation
11%
Signaling Protein
11%
Cyclin D1
11%
Adenovirus Vector
11%
Synapsin I
10%
Binding Protein
10%
Gene Expression
10%
KMT2A
10%
mTOR Signaling
9%
IRF4
9%
G1/S Transition
9%
ETV6
9%
Chromosomal Rearrangement
9%
AKT1
9%
DNA Repair
9%
Adenosine Monophosphate
9%
In Vitro Study
9%
Germ Cell
9%
Germline
9%
Genetic Mechanism
9%
Cancer Cell
9%
MicroRNA
9%
RNA Sequencing
9%
Gene Expression Profiling
9%
Cytokine
8%
Cyclin D3
8%
Western Blot
8%
B Cell
8%
